Outcomes of blood and marrow transplantation in children less than 2-years of age: 23 years of experience at a single center

OBJECTIVES: Allogeneic hematopoietic cell transplantation (Allo-HCT) is a curative option for children with various malignant and non-malignant diseases. Most reports studied all age groups amongst children. Herein we analyzed our data in children transplanted at or less than 2-years of age. PATIENT...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Saadiya, Siddiqui, Khawar, ElSolh, Hasan, AlJefri, Abdullah, AlAhmari, Ali, Ghemlas, Ibrahim, AlSaedi, Hawazen, AlEnazi, Awatif, AlSeraihi, Amal, Ayas, Mouhab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019952/
https://www.ncbi.nlm.nih.gov/pubmed/36937328
http://dx.doi.org/10.1016/j.ijpam.2022.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019952/
https://www.ncbi.nlm.nih.gov/pubmed/36937328
http://dx.doi.org/10.1016/j.ijpam.2022.09.002

Ejemplares similares